# BIOGEN INC. (BIIB) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from BIOGEN INC.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/BIIB/mda/fy2025/): filed 2026-02-06; accession 0000875045-26-000013 (https://www.sec.gov/Archives/edgar/data/875045/000087504526000013/biib-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/BIIB/mda/fy2024/): filed 2025-02-12; accession 0000875045-25-000009 (https://www.sec.gov/Archives/edgar/data/875045/000087504525000009/biib-20241231.htm)
- [FY 2023 MD&A](/company/BIIB/mda/fy2023/): filed 2024-02-14; accession 0000875045-24-000009 (https://www.sec.gov/Archives/edgar/data/875045/000087504524000009/biib-20231231.htm)
- [FY 2022 MD&A](/company/BIIB/mda/fy2022/): filed 2023-02-15; accession 0000875045-23-000009 (https://www.sec.gov/Archives/edgar/data/875045/000087504523000009/biib-20221231.htm)
- [FY 2021 MD&A](/company/BIIB/mda/fy2021/): filed 2022-02-03; accession 0000875045-22-000007 (https://www.sec.gov/Archives/edgar/data/875045/000087504522000007/biib-20211231.htm)

Back to /company/BIIB/